We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bills in Senate, House Aim to Restrict Authorized Generics
Bills in Senate, House Aim to Restrict Authorized Generics
February 25, 2011
In an effort to stem pay-for-delay agreements, Sen. Jay Rockefeller (D-W.Va.) has reintroduced legislation that would stop brand-drug makers from marketing an authorized generic during a generic-drug maker’s 180-day marketing exclusivity period.